Related Experiment Video
Updated: May 4, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Significance of the development of a cardiovascular disease surveillance and reporting system in India
1Division of Global Health Sciences, School of Medicine, University of California, San Francisco, California, USA.
Insights
Cardiovascular disease (CVD) surveillance in India needs a centralized, WHO STEP-wise model approach. Implementing this system will improve early detection and targeted interventions for CVD risk factors.
Area of Science:
- Public Health
- Epidemiology
- Health Policy
Background:
- Cardiovascular disease (CVD) is a leading cause of death globally and in the Indian subcontinent.
- Projected increases in CVD deaths highlight the urgent need for robust monitoring of risk factors.
- Existing surveillance systems lack comprehensive evaluation, necessitating a structured approach.
Purpose of the Study:
- To propose a framework for a national CVD surveillance and monitoring & evaluation (M&E) program in India.
- To leverage the World Health Organization's STEP-wise model for effective CVD risk factor surveillance.
- To outline recommendations for the Ministry of Health for establishing a centralized CVD surveillance system.
Main Methods:
- Adoption of the WHO STEP-wise model for CVD surveillance.
- Development of process measures for local-level early CVD detection.
- Establishment of a data reporting system with incentives for accuracy and data-driven interventions.
- Creation of health policies mandating data use for targeted prevention and capacity building.
Main Results:
- A proposed surveillance system structure with defined roles for local, state, and central monitoring teams.
- Emphasis on data-driven evidence for targeted interventions and prevention strategies.
- Anticipated cost and social benefits from an evidence-based, data-driven approach.
- Recommendations for future research on data critique, incentivized reporting, and international comparisons.
Conclusions:
- A centralized, data-driven CVD surveillance system based on the WHO STEP-wise model is crucial for India.
- The proposed system offers significant cost and social benefits, providing a business case for scale-up.
- Further research is needed to refine the system, address challenges, and explore alternative strategies.
Abstract:
Cardiovascular disease (CVD) is the single largest cause of global morbidity and mortality and is the leading cause of death in the Indian subcontinent projected to contribute to deaths expected to double by 2015. The social and economic impact of these staggering projections highlight the need for a centralized effort to monitor and evaluate behavioral and physiological risk factors for CVD. Limited evidence on existing surveillance systems suggest that the key to an effective monitoring and evaluation (M and E) program for CVD surveillance in India relies upon the World Health Organization's STEP-wise model. Key recommendations for the Ministry of Health include the development of a national CVD surveillance program with expertise and a quality-improvement mechanism to receive continuous input from similar surveillance programs in likeminded countries. Structure of the surveillance system would include; (1) the development of process measures for CVD risk factor' based surveillance M and E systems for early detection of CVD at the local-level, (2) the development of trigger based data reporting responsibilities to State-based monitoring teams including incentives for accuracy in data reporting and the use of data-driven evidence to target risk specific intervention and prevention on Central Government monitoring teams with reporting feedback to the State and local-levels and (3) the creation of health policy to require the use of data to target risk specific prevention for intervention and developing local technical capacity. Such a system would provide significant cost and social benefits, presenting an evidence based data driven cost-effective business case for scale-up and potential use in areas comprising similar demographics. Future research should focus on the inclusion of a systematic critique of the reported data for the challenges to surveillance systems in India and the examination of the effect of an incentivized reporting system on the states. Further inquiry into the types of reporting and lessons from other countries' surveillance programs with alternative strategies to a national approach should address potential imitations at the ground or peripheral levels.
Related Concept Videos
Principles of Disease Surveillance
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Assessment of the Cardiovascular System II: Inspection
Head and Neck
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease IV: Preventive Measures

